162 related articles for article (PubMed ID: 28885730)
21. Differential roles of p80- and p130-angiomotin in the switch between migration and stabilization of endothelial cells.
Ernkvist M; Birot O; Sinha I; Veitonmaki N; Nyström S; Aase K; Holmgren L
Biochim Biophys Acta; 2008 Mar; 1783(3):429-37. PubMed ID: 18164266
[TBL] [Abstract][Full Text] [Related]
22. AMOTL1 enhances YAP1 stability and promotes YAP1-driven gastric oncogenesis.
Zhou Y; Zhang J; Li H; Huang T; Wong CC; Wu F; Wu M; Weng N; Liu L; Cheng ASL; Yu J; Wong N; Lo KW; Tang PMK; Kang W; To KF
Oncogene; 2020 May; 39(22):4375-4389. PubMed ID: 32313226
[TBL] [Abstract][Full Text] [Related]
23. Angiomotin-p130 inhibits vasculogenic mimicry formation of small cell lung cancer independently of Smad2/3 signal pathway.
Li D; Shen Y; Ren H; Wang L; Yang J; Wang Y
J Bioenerg Biomembr; 2021 Jun; 53(3):295-305. PubMed ID: 33712992
[TBL] [Abstract][Full Text] [Related]
24. Overexpression of the YAP1 oncogene in clear cell renal cell carcinoma is associated with poor outcome.
Rybarczyk A; Klacz J; Wronska A; Matuszewski M; Kmiec Z; Wierzbicki PM
Oncol Rep; 2017 Jul; 38(1):427-439. PubMed ID: 28504812
[TBL] [Abstract][Full Text] [Related]
25. Clinicopathologic characteristics of YES-associated protein 1 overexpression and its relationship to tumor biomarkers in gastric cancer.
Zhang J; Yang YC; Zhu JS; Zhou Z; Chen WX
Int J Immunopathol Pharmacol; 2012; 25(4):977-87. PubMed ID: 23298488
[TBL] [Abstract][Full Text] [Related]
26. YAP1-Mediated Suppression of USP31 Enhances NFκB Activity to Promote Sarcomagenesis.
Ye S; Lawlor MA; Rivera-Reyes A; Egolf S; Chor S; Pak K; Ciotti GE; Lee AC; Marino GE; Shah J; Niedzwicki D; Weber K; Park PMC; Alam MZ; Grazioli A; Haldar M; Xu M; Perry JA; Qi J; Eisinger-Mathason TSK
Cancer Res; 2018 May; 78(10):2705-2720. PubMed ID: 29490948
[TBL] [Abstract][Full Text] [Related]
27. The correlation between poor prognosis and increased yes-associated protein 1 expression in keratin 19 expressing hepatocellular carcinomas and cholangiocarcinomas.
Lee K; Lee KB; Jung HY; Yi NJ; Lee KW; Suh KS; Jang JJ
BMC Cancer; 2017 Jun; 17(1):441. PubMed ID: 28645247
[TBL] [Abstract][Full Text] [Related]
28. Role of yes-associated protein 1, angiomotin, and mitogen-activated kinase kinase 1/2 in development of the bovine blastocyst.
Negrón-Pérez VM; Hansen PJ
Biol Reprod; 2018 Feb; 98(2):170-183. PubMed ID: 29228123
[TBL] [Abstract][Full Text] [Related]
29. Overexpression of Yes Associated Protein 1, an Independent Prognostic Marker in Patients With Pancreatic Ductal Adenocarcinoma, Correlated With Liver Metastasis and Poor Prognosis.
Salcedo Allende MT; Zeron-Medina J; Hernandez J; Macarulla T; Balsells J; Merino X; Allende H; Tabernero J; Ramon Y Cajal S
Pancreas; 2017 Aug; 46(7):913-920. PubMed ID: 28697132
[TBL] [Abstract][Full Text] [Related]
30. Expression of Yes-associated protein 1 and its clinical significance in ovarian serous cystadenocarcinoma.
Cho SY; Kim K; Park MS; Jang MY; Choi YH; Han S; Shin HM; Chung C; Han HY; Yang JB; Ko YB; Yoo HJ
Oncol Rep; 2017 May; 37(5):2620-2632. PubMed ID: 28339095
[TBL] [Abstract][Full Text] [Related]
31. Activation of YAP1 is associated with poor prognosis and response to taxanes in ovarian cancer.
Jeong W; Kim SB; Sohn BH; Park YY; Park ES; Kim SC; Kim SS; Johnson RL; Birrer M; Bowtell DSL; Mills GB; Sood A; Lee JS
Anticancer Res; 2014 Feb; 34(2):811-817. PubMed ID: 24511017
[TBL] [Abstract][Full Text] [Related]
32. Angiomotin promotes the malignant potential of colon cancer cells by activating the YAP-ERK/PI3K-AKT signaling pathway.
Zhang Y; Yuan J; Zhang X; Yan F; Huang M; Wang T; Zheng X; Zhang M
Oncol Rep; 2016 Dec; 36(6):3619-3626. PubMed ID: 27779692
[TBL] [Abstract][Full Text] [Related]
33. NEDD9 overexpression correlates with poor prognosis in gastric cancer.
Liu Y; Wang D; Zhao KL; Zhu JW; Yin HB; Wei YZ; Wu ZJ; Cheng GJ; Wang F; Ni F; Wang XL; Cao GX; Huang J; Cai J
Tumour Biol; 2014 Jul; 35(7):6351-6. PubMed ID: 24664584
[TBL] [Abstract][Full Text] [Related]
34. The association between the expression of nuclear Yes-associated protein 1 (YAP1) and p53 protein expression profile in breast cancer patients.
Cha YJ; Kim D; Bae SJ; Ahn SG; Jeong J; Cho MK; Paik PS; Yoo TK; Park WC; Yoon CI
PLoS One; 2021; 16(5):e0250986. PubMed ID: 33970925
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of Yes-Associated Protein 1 (YAP1) in Various Cancers: A Meta-Analysis.
Sun Z; Xu R; Li X; Ren W; Ou C; Wang Q; Zhang H; Zhang X; Ma J; Wang H; Li G
PLoS One; 2015; 10(8):e0135119. PubMed ID: 26263504
[TBL] [Abstract][Full Text] [Related]
36. Angiomotins stimulate LATS kinase autophosphorylation and act as scaffolds that promote Hippo signaling.
Mana-Capelli S; McCollum D
J Biol Chem; 2018 Nov; 293(47):18230-18241. PubMed ID: 30266805
[TBL] [Abstract][Full Text] [Related]
37. Prognostic significance of nuclear Yes-associated protein 1 in patients with nonsmall cell lung cancer: A systematic review and meta-analysis.
Zhu L; Ma G; Liu J; Deng Y; Wu Q; Chen W; Zhou Q
Medicine (Baltimore); 2019 Apr; 98(16):e15069. PubMed ID: 31008931
[TBL] [Abstract][Full Text] [Related]
38. Regulation of localization and function of the transcriptional co-activator YAP by angiomotin.
Moleirinho S; Hoxha S; Mandati V; Curtale G; Troutman S; Ehmer U; Kissil JL
Elife; 2017 May; 6():. PubMed ID: 28464980
[TBL] [Abstract][Full Text] [Related]
39. High tissue MMP14 expression predicts worse survival in gastric cancer, particularly with a low PROX1.
Kasurinen A; Gramolelli S; Hagström J; Laitinen A; Kokkola A; Miki Y; Lehti K; Yashiro M; Ojala PM; Böckelman C; Haglund C
Cancer Med; 2019 Nov; 8(16):6995-7005. PubMed ID: 31560170
[TBL] [Abstract][Full Text] [Related]
40. Fragment-based exploration of the 14-3-3/Amot-p130 interface.
Centorrino F; Andlovic B; Cossar P; Brunsveld L; Ottmann C
Curr Res Struct Biol; 2022; 4():21-28. PubMed ID: 35036934
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
